JPRN-UMIN000011241已完成未知
The effects of budesonide/formoterol maintenance and reliever therapy on airway inflammation in asthma patients; open label, randomized parallel group comparison study with fluticasone/salmeterol - The effects of SMART on airway inflammation in asthma patients
Hiroshima Allergy and Respiratory Clinic0 个研究点目标入组 30 人开始时间: 2013年7月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Patients with a history of hypersensitivity (including contact dermatitis) to any ingredient contained in the study drugs -Patients with infections with no available effective antimicrobial drugs or with deep seated mycosis -Patients with tuberculosis -Patients with rhinitis needed to be treated clinically -Respiratory infection, judged by the investigator as an infection affecting the asthma, within 8 weeks prior to enrollment -Use of any beta-blocking agents (including eye-drops) -Treatment with oral, parenteral or rectal steroids within 30 days prior to enrollment -Any significant disease or disorder judged by the investigator -Current or previous with a smoking history,10 pack years or more, or smoking cessation no longer than 6 months prior to enrollment -Pregnancy, breast-feeding or planned pregnancy during the study -Suspected poor capability, as judged by the investigator
研究者
相似试验
已完成
不适用
Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmaticsJPRN-UMIN000004275Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine10
已完成
不适用
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drugBronchial asthmaJPRN-UMIN000003805JA Tohno Kousei Hospital40
已完成
不适用
Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthmaPatients with bronchial asthma aged 20 years and older (males and females, outpatients and inpatients) being treated with an ICS (at a dose equivalent to FP 200-1000 mcg/day) and salmeterol 100 mcg/day in combination (either as two separate products or one combined product) for 3 months or longer with poor or inadequate controlJPRN-UMIN000006572Chiba-Hokusoh Hospital, Nippon Medical School80
已完成
不适用
Clinical effects of budesonide/formoterol in patients with asthmaBronchial asthmaJPRN-UMIN000003745Atami Hospital International University of Health and Welfare30
招募中
不适用
Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma in 4-week treatment;Open-label, randomized, parallel-group comparative studyBronchial asthmaJPRN-UMIN000017042Hiroshima Allergy and Respiratory Clinic30